2026 Global: Bioprocess Validation Market-Competitive Review (2032) report
Description
The 2026 Global: Bioprocess Validation Market-Competitive Review (2031) report features the global market size and projected growth/decline data for the period 2021 through 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bioprocess validation market by geography and historical trend. The scope of the report extends to sizing of the bioprocess validation market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Eurofins Scientific, Sartorius AG, Merck KGaA, Thermo Fisher Scientific Inc., Lonza, Danaher Corporation, Charles River Laboratories, SGS Société Générale de Surveillance, Pall Corporation, and Cytiva lead the bioprocess validation market, providing critical services and technologies for ensuring compliance in biopharmaceutical manufacturing.
Eurofins Scientific excels in outsourced validation services, offering regulatory expertise for biologics and compliance with FDA/EMA standards, supporting small-to-midsize biotechs through advanced testing labs and extractables/leachables analysis. Sartorius AG delivers innovative filtration systems, single-use technologies, and process analytics, operating in over 110 countries to enhance sterility assurance and efficiency in vaccine and cell therapy production. Merck KGaA specializes in membrane filters, cartridges, and single-use systems for upstream/downstream processes, ensuring contamination-free manufacturing of monoclonal antibodies and gene therapies across 70+ countries. Thermo Fisher Scientific Inc. provides comprehensive analytical tools and validation protocols, bolstering bioreactor and bioprocessing scalability for global biopharma firms. Lonza advances capacity through strategic CMO alliances, enabling rapid commercialization of mRNA and cell therapies with greenlit facilities like its EMA-approved site in Ireland.
Danaher Corporation offers cartridge filters and high-throughput solutions for regulatory-compliant production, aiding research-to-commercial transitions in biologics and vaccines worldwide. Charles River Laboratories focuses on safety testing and viral clearance validation, critical for patient safety in advanced therapies. SGS Société Générale de Surveillance delivers global inspection and certification, accelerating market entry via third-party expertise in cleanroom and filling validation. Pall Corporation supplies sterile filtration for bioprocess integrity, reducing errors in high-volume manufacturing. Cytiva (part of Danaher) innovates in single-use bioprocessing and chromatography, driving efficiency in continuous manufacturing and EU GMP Annex 1 compliance. These firms collectively fuel 10.5% CAGR growth through automation, AI analytics, and sustainable protocols.
Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2021 to 2032 using regression analysis in our modeling. and Perry/Hope is the only market research publisher that utilizes both longitudinal (historical) and vertical (from market section to market division to market class) analysis, since we study every manufactured product in the countries we analyze. The report also provides written analysis on the market definition, market segments, and SWOT analysis (market strengths, weaknesses, opportunities, and threats).
The market study aims at estimating the market size and the growth potential of this market. Topics analyzed within the report include a detailed breakdown of the global markets for bioprocess validation market by geography and historical trend. The scope of the report extends to sizing of the bioprocess validation market market and global market trends with market data for 2024 as the base year, 2025 and 2026 as the estimate years with projection of CAGR from 2027 to 2032.
The report also features a list of the top ten largest global players in the market. A review of each company includes 1) an estimate of the market share, 2) a listing of the products and/or services in the market, and 3) the features of these products and/or services in the market. The report has a chapter on Comparative Business Strategies for the largest four players. An example of the Comparative Business Strategies analysis would be -- How does Netflix's business strategy to expand its market share in the global online streaming compare to Amazon Prime's business strategy through its video products and services?
The ten market players in this report and a brief synopsis of their participation in the market are:
Eurofins Scientific, Sartorius AG, Merck KGaA, Thermo Fisher Scientific Inc., Lonza, Danaher Corporation, Charles River Laboratories, SGS Société Générale de Surveillance, Pall Corporation, and Cytiva lead the bioprocess validation market, providing critical services and technologies for ensuring compliance in biopharmaceutical manufacturing.
Eurofins Scientific excels in outsourced validation services, offering regulatory expertise for biologics and compliance with FDA/EMA standards, supporting small-to-midsize biotechs through advanced testing labs and extractables/leachables analysis. Sartorius AG delivers innovative filtration systems, single-use technologies, and process analytics, operating in over 110 countries to enhance sterility assurance and efficiency in vaccine and cell therapy production. Merck KGaA specializes in membrane filters, cartridges, and single-use systems for upstream/downstream processes, ensuring contamination-free manufacturing of monoclonal antibodies and gene therapies across 70+ countries. Thermo Fisher Scientific Inc. provides comprehensive analytical tools and validation protocols, bolstering bioreactor and bioprocessing scalability for global biopharma firms. Lonza advances capacity through strategic CMO alliances, enabling rapid commercialization of mRNA and cell therapies with greenlit facilities like its EMA-approved site in Ireland.
Danaher Corporation offers cartridge filters and high-throughput solutions for regulatory-compliant production, aiding research-to-commercial transitions in biologics and vaccines worldwide. Charles River Laboratories focuses on safety testing and viral clearance validation, critical for patient safety in advanced therapies. SGS Société Générale de Surveillance delivers global inspection and certification, accelerating market entry via third-party expertise in cleanroom and filling validation. Pall Corporation supplies sterile filtration for bioprocess integrity, reducing errors in high-volume manufacturing. Cytiva (part of Danaher) innovates in single-use bioprocessing and chromatography, driving efficiency in continuous manufacturing and EU GMP Annex 1 compliance. These firms collectively fuel 10.5% CAGR growth through automation, AI analytics, and sustainable protocols.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
